PCA
TNDM icon

Prospect Capital Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Prospect Capital Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-127,900
Closed -$7.62M – 25
2019
Q4 		$7.62M Buy
+127,900
New +$7.89M 4.68% 9

Other funds holding TNDM

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Prospect Capital Advisors's TNDM Position: Q1 2020 in Review

Prospect Capital Advisors sold out of Tandem Diabetes Care (TNDM) in Q1 2020, closing a stake of 127,900 shares — an estimated $7.62M sold.

Prospect Capital Advisors first reported a position in TNDM in Q4 2019 and held it in 1 quarter. The position peaked at $7.62M in Q4 2019. 279 funds tracked by Wall St. Rank hold TNDM as of Q1 2020.

  • Prospect Capital Advisors reported no remaining Tandem Diabetes Care position as of Q1 2020 after selling out during the quarter.
  • Prospect Capital Advisors sold 127,900 Tandem Diabetes Care shares in Q1 2020, an estimated $7.62M.
  • Prospect Capital Advisors first reported a position in Tandem Diabetes Care in Q4 2019 and held it in 1 quarter.
  • Prospect Capital Advisors's Tandem Diabetes Care position peaked at $7.62M in Q4 2019.
  • 279 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2020.

Based on Prospect Capital Advisors's 13F filing for Q1 2020, filed 15 May 2020.